Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study

LaTeX / BibTeX

@article{cerqueirasilva2022effectivenessofcoronavac,
  author = {Thiago Cerqueira-Silva and Jason R Andrews and Viviane S Boaventura and Otavio T Ranzani and Vinicius de Araújo Oliveira and Enny S Paixão and Juracy Bertoldo Júnior and Tales Mota Machado and Matt D T Hitchings and Murilo Dorion and Margaret L Lind and Gerson O Penna and Derek A T Cummings and Natalie E Dean and Guilherme Loureiro Werneck and Neil Pearce and Mauricio L Barreto and Albert I Ko and Julio Croda and Manoel Barral-Netto},
  title = {Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study},
  year = {2022},
  journal = {The Lancet Infectious Diseases},
  doi = {10.1016/s1473-3099(22)00140-2},
  url = {https://doi.org/10.1016/s1473-3099(22)00140-2}
}